Mesquite

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease2 trials

Phase

• Phase 32 trials

Status

• Completed1 trial
• Terminated1 trial

Lead sponsor

• Otsuka Pharmaceutical Development & Commercialization, Inc.2 trials

Closed trials

• Completed

  Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

  NCT03393520· Phase 3· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

• Terminated

  Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

  NCT02446132· Phase 3· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source